After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that 10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
10x Genomics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Health Information Services industry. The current market capitalization of 10x Genomics Inc is $5.43B. A total of 0.99 million shares were traded on the day, compared to an average of 1.27M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, TXG has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 14 BUYs and 44 SELLs from insiders. Insiders purchased 364,400 shares during that period but sold 151,536.
In the most recent transaction, Saxonov Serge sold 2,821 shares of TXG for 46.34 per share on Feb 22. After the transaction, the Chief Executive Officer now owns 847,560 company shares. In a previous transaction on Feb 22, Hindson Benjamin J. sold 2,613 shares at 46.34 per share. TXG shares that the insider owns now total 283,059.
Among the insiders who sold shares, McAnear Justin J. disposed of 1,865 shares on Feb 22 at a per-share price of $46.34. This resulted in the Chief Financial Officer holding 95,240 shares of TXG after the transaction. In another insider transaction, Saxonov Serge sold 5,000 shares at $48.87 per share on Feb 15. Company shares held by the Chief Executive Officer now total 850,381.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, TXG has a high of $63.57 and a low of $33.79.
As of this writing, TXG has an earnings estimate of -$0.51 per share for the current quarter. EPS was calculated based on a consensus of 14 estimates, with a high estimate of -$0.4 per share and a lower estimate of -$0.65. The company reported an EPS of -$0.79 in the last quarter, which was -71.70% lower than expectations of -$0.46.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TXG’s latest balance sheet shows that the firm has $587.45M in Cash & Short Term Investments as of fiscal 2021. There were $81.98M in debt and $110.36M in liabilities at the time. Its Book Value Per Share was $6.22, while its Total Shareholder’s Equity was $817.57M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TXG is Buy with a score of 4.31.
